Albuferon: Final Phase I/II data

In the open-label, dose-escalation Phase I/II trial in 119 patients

Read the full 107 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE